For Jazz Pharmaceuticals, Failure Is the New Winning
April 06, 2021 at 05:04 AM EDT
In late June, Jazz Pharmaceuticals began to market a drug aimed at treating people whose metastatic small cell lung cancer has not responded to an initial round of chemotherapy.